US Stock MarketDetailed Quotes

Ensysce Biosciences (ENSC)

Watchlist
  • 0.9300
  • +0.0046+0.50%
Close Jan 14 16:00 ET
3.38MMarket Cap-0.27P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ensysce Biosciences (ENSC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
680.24%3.74M
-10.48%1.75M
6.76%1.97M
-37.21%6.73M
13.33%3.58M
-123.81%-644.75K
-14.76%1.96M
-28.04%1.84M
-55.75%10.72M
-49.11%3.16M
Selling and administrative expenses
18.08%1.28M
0.72%1.2M
2.33%1.4M
-11.95%4.72M
-25.07%1.08M
-11.75%1.08M
4.32%1.19M
-11.90%1.37M
-22.41%5.36M
20.60%1.44M
-General and administrative expense
18.08%1.28M
0.72%1.2M
2.33%1.4M
-11.95%4.72M
-25.07%1.08M
-11.75%1.08M
4.32%1.19M
-11.90%1.37M
-22.41%5.36M
20.60%1.44M
Research and development costs
74.78%2.95M
103.06%1.92M
142.07%1.89M
-4.85%7.22M
70.31%3.8M
-11.71%1.69M
-42.37%947.23K
-56.63%778.9K
-61.75%7.59M
-65.34%2.23M
Other operating expenses
85.58%-493.1K
-654.38%-1.37M
-331.69%-1.32M
-133.58%-5.21M
-153.12%-1.3M
-685.26%-3.42M
62.93%-181.8K
61.28%-305.72K
11.61%-2.23M
64.07%-515.03K
Operating profit
-680.24%-3.74M
10.48%-1.75M
-6.76%-1.97M
37.21%-6.73M
-13.33%-3.58M
123.81%644.75K
14.76%-1.96M
28.04%-1.84M
55.75%-10.72M
49.11%-3.16M
Net non-operating interest income expense
-56.76%-6.37K
88.54%-3.16K
99.69%-3.86K
-264.59%-1.29M
96.88%-10.75K
46.88%-4.06K
-27.56K
-83,271.08%-1.25M
92.90%-353.95K
-386.44%-344.8K
Non-operating interest expense
56.76%6.37K
-88.54%3.16K
-99.69%3.86K
264.59%1.29M
-96.88%10.75K
-46.88%4.06K
--27.56K
83,271.08%1.25M
223.16%353.95K
564.83%344.8K
Other net income (expense)
-13.04%18.34K
32.51%20.16K
201.02%25.8K
-92.47%33.57K
688.26%22.81K
-12.71%21.09K
-72.17%15.21K
-106.88%-25.53K
-91.08%445.86K
-100.49%-3.88K
Other non- operating income (expenses)
-13.04%18.34K
32.51%20.16K
201.02%25.8K
-92.47%33.57K
-84.01%22.81K
-12.71%21.09K
-72.17%15.21K
-111.38%-25.53K
-91.08%445.86K
-97.95%142.6K
Income before tax
-663.51%-3.73M
11.91%-1.73M
37.57%-1.95M
24.84%-7.99M
-1.71%-3.56M
124.59%661.77K
12.12%-1.97M
-42.19%-3.12M
56.10%-10.63M
36.03%-3.5M
Income tax
Net income
-663.51%-3.73M
11.91%-1.73M
37.57%-1.95M
24.84%-7.99M
-1.71%-3.56M
124.59%661.77K
12.12%-1.97M
-42.19%-3.12M
56.10%-10.63M
36.03%-3.5M
Net income continuous Operations
-663.51%-3.73M
11.91%-1.73M
37.57%-1.95M
24.84%-7.99M
-1.71%-3.56M
124.59%661.77K
12.12%-1.97M
-42.19%-3.12M
56.10%-10.63M
36.03%-3.5M
Minority interest income
0
-166
0
99.44%-74
0
0
0
98.12%-74
62.70%-13.2K
-107.89%-965
Net income attributable to the parent company
-663.51%-3.73M
11.91%-1.73M
37.57%-1.95M
24.74%-7.99M
-1.74%-3.56M
124.61%661.77K
11.85%-1.97M
-42.44%-3.12M
56.09%-10.61M
36.19%-3.5M
Preferred stock dividends
Other preferred stock dividends
0
0
0
-97.76%290
0
0
0
-96.51%290
-98.58%12.94K
-97.16%899
Net income attributable to common stockholders
-663.51%-3.73M
11.91%-1.73M
37.58%-1.95M
24.83%-7.99M
-1.72%-3.56M
124.61%661.77K
11.99%-1.97M
-41.92%-3.12M
57.64%-10.63M
36.54%-3.5M
Basic earnings per share
-229.00%-1.29
76.42%-0.79
83.07%-1.39
83.74%-11.45
85.92%-2.9
107.66%1
77.21%-3.35
73.69%-8.21
96.63%-70.4
92.47%-20.6
Diluted earnings per share
-229.00%-1.29
76.42%-0.79
83.07%-1.39
83.74%-11.45
85.92%-2.9
107.66%1
77.21%-3.35
73.69%-8.21
96.63%-70.4
92.47%-20.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 680.24%3.74M-10.48%1.75M6.76%1.97M-37.21%6.73M13.33%3.58M-123.81%-644.75K-14.76%1.96M-28.04%1.84M-55.75%10.72M-49.11%3.16M
Selling and administrative expenses 18.08%1.28M0.72%1.2M2.33%1.4M-11.95%4.72M-25.07%1.08M-11.75%1.08M4.32%1.19M-11.90%1.37M-22.41%5.36M20.60%1.44M
-General and administrative expense 18.08%1.28M0.72%1.2M2.33%1.4M-11.95%4.72M-25.07%1.08M-11.75%1.08M4.32%1.19M-11.90%1.37M-22.41%5.36M20.60%1.44M
Research and development costs 74.78%2.95M103.06%1.92M142.07%1.89M-4.85%7.22M70.31%3.8M-11.71%1.69M-42.37%947.23K-56.63%778.9K-61.75%7.59M-65.34%2.23M
Other operating expenses 85.58%-493.1K-654.38%-1.37M-331.69%-1.32M-133.58%-5.21M-153.12%-1.3M-685.26%-3.42M62.93%-181.8K61.28%-305.72K11.61%-2.23M64.07%-515.03K
Operating profit -680.24%-3.74M10.48%-1.75M-6.76%-1.97M37.21%-6.73M-13.33%-3.58M123.81%644.75K14.76%-1.96M28.04%-1.84M55.75%-10.72M49.11%-3.16M
Net non-operating interest income expense -56.76%-6.37K88.54%-3.16K99.69%-3.86K-264.59%-1.29M96.88%-10.75K46.88%-4.06K-27.56K-83,271.08%-1.25M92.90%-353.95K-386.44%-344.8K
Non-operating interest expense 56.76%6.37K-88.54%3.16K-99.69%3.86K264.59%1.29M-96.88%10.75K-46.88%4.06K--27.56K83,271.08%1.25M223.16%353.95K564.83%344.8K
Other net income (expense) -13.04%18.34K32.51%20.16K201.02%25.8K-92.47%33.57K688.26%22.81K-12.71%21.09K-72.17%15.21K-106.88%-25.53K-91.08%445.86K-100.49%-3.88K
Other non- operating income (expenses) -13.04%18.34K32.51%20.16K201.02%25.8K-92.47%33.57K-84.01%22.81K-12.71%21.09K-72.17%15.21K-111.38%-25.53K-91.08%445.86K-97.95%142.6K
Income before tax -663.51%-3.73M11.91%-1.73M37.57%-1.95M24.84%-7.99M-1.71%-3.56M124.59%661.77K12.12%-1.97M-42.19%-3.12M56.10%-10.63M36.03%-3.5M
Income tax
Net income -663.51%-3.73M11.91%-1.73M37.57%-1.95M24.84%-7.99M-1.71%-3.56M124.59%661.77K12.12%-1.97M-42.19%-3.12M56.10%-10.63M36.03%-3.5M
Net income continuous Operations -663.51%-3.73M11.91%-1.73M37.57%-1.95M24.84%-7.99M-1.71%-3.56M124.59%661.77K12.12%-1.97M-42.19%-3.12M56.10%-10.63M36.03%-3.5M
Minority interest income 0-166099.44%-7400098.12%-7462.70%-13.2K-107.89%-965
Net income attributable to the parent company -663.51%-3.73M11.91%-1.73M37.57%-1.95M24.74%-7.99M-1.74%-3.56M124.61%661.77K11.85%-1.97M-42.44%-3.12M56.09%-10.61M36.19%-3.5M
Preferred stock dividends
Other preferred stock dividends 000-97.76%290000-96.51%290-98.58%12.94K-97.16%899
Net income attributable to common stockholders -663.51%-3.73M11.91%-1.73M37.58%-1.95M24.83%-7.99M-1.72%-3.56M124.61%661.77K11.99%-1.97M-41.92%-3.12M57.64%-10.63M36.54%-3.5M
Basic earnings per share -229.00%-1.2976.42%-0.7983.07%-1.3983.74%-11.4585.92%-2.9107.66%177.21%-3.3573.69%-8.2196.63%-70.492.47%-20.6
Diluted earnings per share -229.00%-1.2976.42%-0.7983.07%-1.3983.74%-11.4585.92%-2.9107.66%177.21%-3.3573.69%-8.2196.63%-70.492.47%-20.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.17%
Sample Name
Sample Code
 +1.87%
Sample Name
Sample Code
 +1.81%
4
AT&T
T
+1.33%
5
Interactive Brokers
IBKR
+1.08%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +23.99%
Sample Name
Sample Code
 +22.01%
Sample Name
Sample Code
 +15.78%
4
GDS Holdings
GDS
+14.31%
5
ASE Technology
ASX
+7.15%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -